Alnylam Pharmaceuticals Share Holder Equity 2010-2024 | ALNY

Alnylam Pharmaceuticals share holder equity for the quarter ending September 30, 2024 was $0.032B, a 119.51% decline year-over-year.

  • Alnylam Pharmaceuticals share holder equity for 2023 was $-0.221B, a 39.45% increase from 2022.
  • Alnylam Pharmaceuticals share holder equity for 2022 was $-0.158B, a 126.9% decline from 2021.
  • Alnylam Pharmaceuticals share holder equity for 2021 was $0.588B, a 42.12% decline from 2020.

Alnylam Pharmaceuticals Share Holder Equity 2010-2024 | ALNY

  • Alnylam Pharmaceuticals share holder equity for 2023 was $-0.221B, a 39.45% increase from 2022.
  • Alnylam Pharmaceuticals share holder equity for 2022 was $-0.158B, a 126.9% decline from 2021.
  • Alnylam Pharmaceuticals share holder equity for 2021 was $0.588B, a 42.12% decline from 2020.